Answers are grounded in this paper and cite their sources.
A truly novel strategy for fabricating reducible supramolecular assemblies based on the host–guest interaction between cucurbit[8]uril (CB[8]) and methyl viologen (MV) is reported. The anticancer drug doxorubicin is loaded into the assemblies and a reducing agent Na2S2O4 can be used to successfully trigger release of drugs because of the redox chemistry of MV.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: